When a cancer cell leaves the original tumor to spread to a new, faraway location, it first has to survive what most cells ...
Our population is aging. The United Nations reports that by 2050, the number of people age 85 and older on our planet is set ...
As a new study links consumption of ultra-processed foods to higher dementia risk, here’s what you can do to protect your ...
Australia's All G has debuted its precision-fermented bovine lactoferrin in the US as it plans a second facility and expects ...
The Northwestern facility will be the nation’s first open automated lab for designing, building, and testing proteins.
Protein production in insect cells or in whole insects could move past the trade-off long associated with conventional ...
Magnitude of EO2463-induced CD8 T-cell expansion during monotherapy statistically significantly associated with longer progression-free survival (PFS) in patients w ...
Patent expands intellectual property protection in one of the world's largest cartilage repair marketsGelrinC is a cell-free hydrogel delivered in a single ~10-minute procedure eliminating the need fo ...
Patent expands intellectual property protection in one of the world's largest cartilage repair marketsGelrinC is a ...
The FDA has approved Lipfendra, the first oral PCSK9 inhibitor, for the treatment of high cholesterol. Two medical experts explain why this matters.
Inhibrx is transitioning from a platform to a clinical-stage biotech, with ozekibart and INBRX-106 as key value drivers.
Pfenex platform that establishes recombinant production as a viable, sustainable, and competitive approach for large-scale ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results